Prescription and cost-analysis of antiemetic medication use in pediatric wards: a prospective observational study
Keywords:Anti-emetic, Children, Drug utilization, Gastroenteritis
Background: Use of anti-emetic drugs in pediatric population is often warranted, but choice of drug remains questionable within pediatricians. Objective of current study is: to study prescribing pattern and to calculate cost of antiemetic drug therapy in pediatric wards.
Methods: A prospective, observational study was conducted in pediatric wards of a tertiary care hospital of over 14 month’s duration. Institutional ethics committee approval was obtained and written informed consent of parents/guardians was taken. Data of any pediatric patient receiving anti-emetic agent were included in the study.
Results: A total of 218 prescriptions were collected. Mean age of patients was 4.39±3.16 (range 4 months to 12 years). Gastroenteritis was the most frequently diagnosed disease in 137(63%) patients. Domperidone was prescribed in 52.4% and ondansetron in 47.6% children. Oral liquid dosage formulation was prescribed in 109 (48.4%) followed by solid dosage form 47 (20.9%). Mean cost of domperidone therapy was 25.34±6.55 INR and for ondansetron it was 36.62±17.94 INR.
Conclusions: Gastroenteritis was most frequent indication for use of anti-emetics. Domperidone pharmacotherapy was cheaper and most frequently prescribed than ondansetron.
Hasler WL, Chey WD. Nausea and vomiting. Gastroenterology. 2003;125:1860–7.
Elliot EJ. Acute Gastroenteritis in children. BMJ. 2007;334:35-40.
King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among children: oral rehydration, maintenance and nutritional therapy. MMWR Recomm Rep. 2003;52:1-16.
Stork CM, Brown KM, Reilly TH, et al. Emergency department treatment of viral gastritis using intravenous ondansetron or dexamethasone in children.Acad Emerg Med. 2006;13:1027-33.
Bass ES, Pappano DA, Humiston SG: Rotavirus. Pediatr Rev. 2007;28:183-91.
Nicole Pfeil, Ulrike Uhlig, KarelKostev, Rita Carius, Helmut Schroder, Wieland Kiess. Antiemetic Medications in Children with Presumed Infectious Gastroenteritis—Pharmacoepidemiology in Europe and Northern America. The Journal of Pediatrics November. 2008;153:659-63.
Kwon KT, Rudkin SE, Langdorf MI. Antiemetic use in pediatric gastroenteritis: a national survey of emergency physicians, pediatricians, and pediatric emergency physicians. Clin Pediatr (Phila). 2002;41(9):641–52.
Li ST, DiGiuseppe DL, Christakis DA. Antiemetic use for acute gastroenteritis in children. Arch Pediatr Adolesc Med. 2003;157(5):475–9.
Ernst AA, Weiss SJ, Park S. Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double-blind clinical trial. Ann Emerg Med. 2000;36:89-94.
American Academy of Pediatrics, Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis. Practice parameter: the management of acute gastroenteritis in young children. Pediatrics. 1996;97:424-35.
Walker-Smith JA, Sandhu BK, Isolauri E, et al. Guidelines prepared by the ESPGAN Working Group on Acute Diarrhoea. Recommendations for feeding in childhood gastroenteritis. European Society of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr. 1997;24(5):619–20.
World Health Organization. The treatment of diarrhoea. A manual for physicians and other senior health care workers, 4th rev ed. World Health Organization. 2005; Available at http://whqlibdoc.who.int/ publications/2005–9241593180.pdf.
Leung AK and Robson WL. Acute gastroenteritis in children: role of antiemetic medication for gastroenteritis related vomiting. Paediatr Drugs. 2007;9:175-84.
Fabio Albano, Eugenia Bruzzese, Maria Immacolata Spagnuolo, and Giulio De Marco.Antiemetics for Children With Gastroenteritis: Off-Label but Still On in Clinical Practice. Journal of Pediatric Gastroenterology and Nutrition. 2006;43:402-4.
Webb A, Starr M. Acute gastroenteritis in children. Aust Fam Physician. 2005;34(4):227–31.
Elliott EJ, Backhouse JA, Leach JW. Pre-admission management of acute gastroenteritis. J Paediatr Child Health. 1996;32(1):18–21.
O’Loughlin EV, Notaras E, McCullough C, et al. Home-based management of children hospitalized with acute gastroenteritis. J Paediatr Child Health. 1995;31(3):189–91.
Menniti-Ippolito F, Traversa G, Da Cas R, et al: Extrapyramidal reactions in children treated with metoclopramide. Ital J Pediatr. 2004;30:49-52.
Cinquetti M, Bonetti P, Bertamini P. Current role of antidopaminergic drugs in pediatrics. Pediatr Med Chir. 2000;22:1-7.
Reeves JJ, Shannon MW, Fleisher GR. Ondansetron decreases vomiting associated with with acute gastroenteritis: a randomized, controlled trial, Pediatrics. 2002;109:1-6.
Ramsook C, Sahagun-Carreon I, Kozinetz CA, et al. A randomized clinical trial comparing oral ondansetron with placebo in children with vomiting from acute gastroenteritis. Ann Emerg Med. 2002; 39:397-403.
Freedman SB, Adler M, Seshadri R, et al. Oral ondansetron for gastroenteritis in a pediatric emergency department. N Engl J Med. 2006;354(16):1698–705.
S Sri Ranganathan, K Mayurathan, R Fernandopulle. A survey on antiemetics prescribed for children in some selected districts of Sri Lanka. Sri Lanka Journal of Child Health. 2010;39:93-7.
World Health Organization (WHO). Introduction to drug utilization research/WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug statistics Methodology, WHO collaborating centre for Drug Utilization Research and Clinical Pharmacological services. Geneva: WHO press, World Health Organization. 2003.
Bhatnagar S, Lodha R, Choudhury P, Sachdev HP, Shah N, Narayan S et al.,IAP Guidelines 2006 on management of acute diarrhea. Indian Pediatr. 2007;44:380-9.
Martindale, Complete drug reference, 36th edition. 2009: 1727.
Cheng A. Emergency department use of oral ondansetron for acute gastroenteritis related vomiting in infants and children. Paediatr Child Health. 2011;16:177-9.
Fedorowicz Z, et al. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database Syst Rev. 2006;18(4):CD005506.
Licensing Medicines for children. Joint report of the British Paediatric Association and the Association of the British Pharmaceutical Industry. London: BPA; 1996.